Abstract:Melatonin is widely present in Nature. It has pleiotropic activities, in part mediated by interactions with high-affinity G-protein-coupled melatonin type 1 and 2 (MT1 and MT2) receptors or under extreme conditions, e.g., ischemia/reperfusion. In pharmacological concentrations, it is given to counteract the massive damage caused by MT1- and MT2-independent mechanisms. The aryl hydrocarbon receptor (AhR) is a perfect candidate for mediating the latter effects because melatonin has structural similarity to its natural ligands, including tryptophan metabolites and indolic compounds. Using a cell-based Human AhR Reporter Assay System, we demonstrated that melatonin and its indolic and kynuric metabolites act as agonists on the AhR with EC50’s between 10−4 and 10−6 M. This was further validated via the stimulation of the transcriptional activation of the CYP1A1 promoter. Furthermore, melatonin and its metabolites stimulated AhR translocation from the cytoplasm to the nucleus in human keratinocytes, as demonstrated by ImageStream II cytometry and Western blot (WB) analyses of cytoplasmic and nuclear fractions of human keratinocytes. These functional analyses are supported by in silico analyses. We also investigated the peroxisome proliferator-activated receptor (PPAR)γ as a potential target for melatonin and metabolites bioregulation. The binding studies using a TR-TFRET kit to assay the interaction of the ligand with the ligand-binding domain (LBD) of the PPARγ showed agonistic activities of melatonin, 6-hydroxymelatonin and N-acetyl-N-formyl-5-methoxykynuramine with EC50’s in the 10−4 M range showing significantly lower affinities that those of rosiglitazone, e.g., a 10−8 M range. These interactions were substantiated by stimulation of the luciferase activity of the construct containing PPARE by melatonin and its metabolites at 10−4 M. As confirmed by the functional assays, binding mode predictions using a homology model of the AhR and a crystal structure of the PPARγ suggest that melatonin and its metabolites, including 6-hydroxymelatonin, 5-methoxytryptamine and N-acetyl-N-formyl-5-methoxykynuramine, are excellent candidates to act on the AhR and PPARγ with docking scores comparable to their corresponding natural ligands. Melatonin and its metabolites were modeled into the same ligand-binding pockets (LBDs) as their natural ligands. Thus, functional assays supported by molecular modeling have shown that melatonin and its indolic and kynuric metabolites can act as agonists on the AhR and they can interact with the PPARγ at high concentrations. This provides a mechanistic explanation for previously reported cytoprotective actions of melatonin and its metabolites that require high local concentrations of the ligands to reduce cellular damage under elevated oxidative stress conditions. It also identifies these compounds as therapeutic agents to be used at pharmacological doses in the prevention or therapy of skin diseases.

Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release

Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics

Structural Basis of the Ligand Binding and Signaling Mechanism of Melatonin Receptors

Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3

Structural basis of ligand recognition at the human MT1 melatonin receptor

Melatonin Represses Mitophagy to Protect Mouse Granulosa Cells from Oxidative Damage

Melatonin Inhibits Cytosolic Mitochondrial Dna-Induced Neuroinflammatory Signaling In Accelerated Aging And Neurodegeneration (Vol 130, 3124, 2021)

Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma

Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin-induced apoptosis in neural cancer cells

Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells

Real-Time Determination of Intracellular cAMP Reveals Functional Coupling of Gs Protein to the Melatonin MT1 Receptor

Dual sources of melatonin and evidence for different primary functions

Melatonin potentiates glycine currents through a PLC/PKC signalling pathway in rat retinal ganglion cells.

Melatonin modulates glycine currents of retinal ganglion cells in rat.

Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions

RGS2 and RGS4 Modulate Melatonin-Induced Potentiation of Glycine Currents in Rat Retinal Ganglion Cells

Melatonin Potentiates Rod Signals To On Type Bipolar Cells In Fish Retina

Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function

Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function

The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions